The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $1.5 million in research grants to researchers at ten institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers. The studies will be conducted over the next two years.
Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet.
Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet.
Eating such foods as broccoli and soy are believed to offer some protection against cancer, but how this occurs is not well-understood.
Having a mother or sister with breast cancer significantly increases the risk for young African American women to develop breast cancer, according to the analysis of questionnaires answered by approximately 59,000 African American women enrolled in the Black Women’s Health Study.
One in three ovarian cancer patients in the U.S. fails to receive the recommended comprehensive surgical treatment.
An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago.
One in three ovarian cancer patients in the U.S. fails to receive the recommended comprehensive surgical treatment, according to a study in the May 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Today Almac Diagnostics announced a major study analysing colorectal polyp tissue samples using its novel Colorectal Cancer DSA? microarray. The DSA? research tool focuses on the transcriptome of an individual disease, in this case colorectal cancer, and contains significant additional data, relevant to the disease of interest that is not available on other generic microarrays.
In North America, ovarian cancer is the second most common gynecological cancer and is the leading cause of death among women with gynecological cancer. The high mortality is in part due to the difficulty of detecting and diagnosing this condition at an early stage.